What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- T cell
Laurence A. Turka spends much of her time researching Immunology, T cell, Cell biology, Transplantation and IL-2 receptor.
Her research integrates issues of Blockade and In vivo in her study of Immunology.
Her T cell study combines topics in areas such as Molecular biology and Antigen.
Her Cell biology research integrates issues from Clonal anergy, Cellular differentiation, Receptor, CTLA-4 and Major histocompatibility complex.
The concepts of her Transplantation study are interwoven with issues in Bioinformatics, Immunosuppression, Allograft Tolerance, Translation and Tolerance induction.
Her study in IL-2 receptor is interdisciplinary in nature, drawing from both Peripheral tolerance, Phosphatidylinositol and MHC class I.
Her most cited work include:
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death (2820 citations)
- Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance (721 citations)
- Deacetylase inhibition promotes the generation and function of regulatory T cells (696 citations)
What are the main themes of her work throughout her whole career to date?
Laurence A. Turka mainly focuses on Immunology, T cell, Cell biology, Transplantation and Immune system.
Immunology is closely attributed to Blockade in her study.
Her biological study spans a wide range of topics, including Cytotoxic T cell and Molecular biology.
Her Cell biology study combines topics from a wide range of disciplines, such as Receptor, IL-2 receptor, Cellular differentiation and FOXP3.
Her research in IL-2 receptor intersects with topics in Peripheral tolerance and Adoptive cell transfer.
Her Transplantation research incorporates themes from Haematopoiesis, Tolerance induction, In vivo and Immunotherapy.
She most often published in these fields:
- Immunology (57.18%)
- T cell (38.83%)
- Cell biology (28.72%)
What were the highlights of her more recent work (between 2014-2021)?
- Immunology (57.18%)
- T cell (38.83%)
- Cell biology (28.72%)
In recent papers she was focusing on the following fields of study:
Laurence A. Turka mostly deals with Immunology, T cell, Cell biology, Immune system and Transplantation.
Immunology is a component of her Immunosuppression, Immune tolerance, IL-2 receptor, B cell and Immunotherapy studies.
She studies T cell, focusing on CD28 in particular.
The various areas that Laurence A. Turka examines in her Cell biology study include Cell growth, Cellular differentiation, Regulatory T cell, FOXP3 and Glutaminolysis.
Her Immune system research is multidisciplinary, incorporating elements of Inflammation, Autoantibody and Antigen.
Her work is dedicated to discovering how Transplantation, Tolerance induction are connected with Confidence interval and other disciplines.
Between 2014 and 2021, her most popular works were:
- Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent (413 citations)
- Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation (348 citations)
- Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability (254 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Internal medicine
Her primary areas of study are Immunology, FOXP3, Cell biology, IL-2 receptor and Regulatory T cell.
Her Immunology study typically links adjacent topics like Hematopoietic stem cell transplantation.
Her studies in FOXP3 integrate themes in fields like Regulation of gene expression, Cancer research, Signal transduction and Kinase.
Laurence A. Turka interconnects Glycolysis, Receptor, Oxidative phosphorylation and Cellular differentiation in the investigation of issues within Cell biology.
Research on T cell and Cytotoxic T cell is a part of her IL-2 receptor study.
Laurence A. Turka has included themes like Adoptive cell transfer, Aldesleukin, Immune tolerance and Monoclonal antibody in her Regulatory T cell study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
